A Trial Comparing GSK1349572 50mg Once Daily to Raltegravir 400mg Twice Daily

Clinical trial NCT01227824 · COMPLETED

Trial details

NCT number: NCT01227824
Sponsor: ViiV Healthcare
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Infection, Human Immunodeficiency Virus I

Start date: 2010-10-19
Primary completion: 2012-02-06
Enrollment: 828

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.